NCT04035837View on ClinicalTrials.gov

The Clinical Cure Project of Chronic Hepatitis B in China

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

30,000

Participants

Timeline

Start Date

May 16, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Hepatitis B, Chronic
Interventions
DRUG

pegylated interferon-alfa

All the patients in this study will receive pegylated interferon for all course.

Trial Locations (1)

510630

Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER